Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency

Background. Limited information exists about the impact of nonalcoholic fatty liver disease (NAFLD) on mild renal insufficiency. We compared the relative influence of NAFLD, metabolic syndrome (MetS), and subclinical inflammation, alone or in combination, on mild renal insufficiency. Methods. This s...

Full description

Bibliographic Details
Main Authors: Ga Eun Nam, Soon Young Hwang, Hye Soo Chung, Ju Hee Choi, Hyun Jung Lee, Nam Hoon Kim, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2018/1835486
id doaj-4fa65ac9a8544b5aa802e33b71b0b373
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ga Eun Nam
Soon Young Hwang
Hye Soo Chung
Ju Hee Choi
Hyun Jung Lee
Nam Hoon Kim
Hye Jin Yoo
Ji-A Seo
Sin Gon Kim
Nan Hee Kim
Sei Hyun Baik
Kyung Mook Choi
spellingShingle Ga Eun Nam
Soon Young Hwang
Hye Soo Chung
Ju Hee Choi
Hyun Jung Lee
Nam Hoon Kim
Hye Jin Yoo
Ji-A Seo
Sin Gon Kim
Nan Hee Kim
Sei Hyun Baik
Kyung Mook Choi
Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
International Journal of Endocrinology
author_facet Ga Eun Nam
Soon Young Hwang
Hye Soo Chung
Ju Hee Choi
Hyun Jung Lee
Nam Hoon Kim
Hye Jin Yoo
Ji-A Seo
Sin Gon Kim
Nan Hee Kim
Sei Hyun Baik
Kyung Mook Choi
author_sort Ga Eun Nam
title Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
title_short Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
title_full Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
title_fullStr Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
title_full_unstemmed Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
title_sort implication of nonalcoholic fatty liver disease, metabolic syndrome, and subclinical inflammation on mild renal insufficiency
publisher Hindawi Limited
series International Journal of Endocrinology
issn 1687-8337
1687-8345
publishDate 2018-01-01
description Background. Limited information exists about the impact of nonalcoholic fatty liver disease (NAFLD) on mild renal insufficiency. We compared the relative influence of NAFLD, metabolic syndrome (MetS), and subclinical inflammation, alone or in combination, on mild renal insufficiency. Methods. This study included 1174 Korean adults. NAFLD was diagnosed using ultrasonography. Mild renal insufficiency was defined as an estimated glomerular filtration rate (eGFR) ≥ 60 and <90 mL/min/1.73 m2. Results. In partial correlation analysis, several components of MetS and liver aminotransferase levels, but not high-sensitivity C-reactive protein (hsCRP), were associated with eGFR. Multivariate logistic regression analysis demonstrated the independent association of NAFLD (P=0.034) and MetS (P=0.018) with mild renal insufficiency, but not elevated hsCRP (P=0.885). Furthermore, NAFLD without the MetS group (odds ratio (95% confidence interval) = 1.56 (1.05–2.34)) or MetS without the NAFLD group (1.82 (1.11–3.00)) was associated with mild renal insufficiency after adjusting for confounding variables. However, individuals with high hsCRP showed no relationship with mild renal insufficiency, irrespective of the existence of NAFLD. Conclusions. This study demonstrated that NAFLD and MetS are independently associated with mild renal insufficiency, whereas subclinical inflammation did not affect the risk for mild renal insufficiency in Korean adults.
url http://dx.doi.org/10.1155/2018/1835486
work_keys_str_mv AT gaeunnam implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT soonyounghwang implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT hyesoochung implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT juheechoi implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT hyunjunglee implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT namhoonkim implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT hyejinyoo implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT jiaseo implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT singonkim implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT nanheekim implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT seihyunbaik implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
AT kyungmookchoi implicationofnonalcoholicfattyliverdiseasemetabolicsyndromeandsubclinicalinflammationonmildrenalinsufficiency
_version_ 1725382900749172736
spelling doaj-4fa65ac9a8544b5aa802e33b71b0b3732020-11-25T00:16:23ZengHindawi LimitedInternational Journal of Endocrinology1687-83371687-83452018-01-01201810.1155/2018/18354861835486Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal InsufficiencyGa Eun Nam0Soon Young Hwang1Hye Soo Chung2Ju Hee Choi3Hyun Jung Lee4Nam Hoon Kim5Hye Jin Yoo6Ji-A Seo7Sin Gon Kim8Nan Hee Kim9Sei Hyun Baik10Kyung Mook Choi11Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDepartment of Biostatistics, College of Medicine, Korea University, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, College of Medicine, Korea University, 80 Guro-dong, Guro-gu, Seoul 152-050, Republic of KoreaBackground. Limited information exists about the impact of nonalcoholic fatty liver disease (NAFLD) on mild renal insufficiency. We compared the relative influence of NAFLD, metabolic syndrome (MetS), and subclinical inflammation, alone or in combination, on mild renal insufficiency. Methods. This study included 1174 Korean adults. NAFLD was diagnosed using ultrasonography. Mild renal insufficiency was defined as an estimated glomerular filtration rate (eGFR) ≥ 60 and <90 mL/min/1.73 m2. Results. In partial correlation analysis, several components of MetS and liver aminotransferase levels, but not high-sensitivity C-reactive protein (hsCRP), were associated with eGFR. Multivariate logistic regression analysis demonstrated the independent association of NAFLD (P=0.034) and MetS (P=0.018) with mild renal insufficiency, but not elevated hsCRP (P=0.885). Furthermore, NAFLD without the MetS group (odds ratio (95% confidence interval) = 1.56 (1.05–2.34)) or MetS without the NAFLD group (1.82 (1.11–3.00)) was associated with mild renal insufficiency after adjusting for confounding variables. However, individuals with high hsCRP showed no relationship with mild renal insufficiency, irrespective of the existence of NAFLD. Conclusions. This study demonstrated that NAFLD and MetS are independently associated with mild renal insufficiency, whereas subclinical inflammation did not affect the risk for mild renal insufficiency in Korean adults.http://dx.doi.org/10.1155/2018/1835486